154 related articles for article (PubMed ID: 37652161)
1. The Impact of Stimulant Medications on Blood Pressure and Body Mass Index in Children with Attention Deficit Hyperactivity Disorder.
Suess M; Chrenka EA; Kharbanda EO; Asche S; O'Connor PJ; Ekstrom H; Benziger CP
Acad Pediatr; 2024 Apr; 24(3):424-432. PubMed ID: 37652161
[TBL] [Abstract][Full Text] [Related]
2. What is the effect of ADHD stimulant medication on heart rate and blood pressure in a community sample of children?
St Amour MD; O'Leary DD; Cairney J; Wade TJ
Can J Public Health; 2018 Jun; 109(3):395-400. PubMed ID: 29981090
[TBL] [Abstract][Full Text] [Related]
3. Attention-Deficit/Hyperactivity Disorder Medication Treatment Impact on Response to Growth Hormone Therapy: Results from the ANSWER Program, a Non-Interventional Study.
Rose SR; Reeves G; Gut R; Germak J
J Pediatr; 2015 Dec; 167(6):1389-96. PubMed ID: 26394822
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.
Hennissen L; Bakker MJ; Banaschewski T; Carucci S; Coghill D; Danckaerts M; Dittmann RW; Hollis C; Kovshoff H; McCarthy S; Nagy P; Sonuga-Barke E; Wong IC; Zuddas A; Rosenthal E; Buitelaar JK;
CNS Drugs; 2017 Mar; 31(3):199-215. PubMed ID: 28236285
[TBL] [Abstract][Full Text] [Related]
5. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
[TBL] [Abstract][Full Text] [Related]
6. Stimulant Medication Treatment in Children with Congenital Heart Disease and Attention-Deficit/Hyperactivity Disorder: Cardiovascular Outcomes.
Trairatvorakul P; Meinzen-Derr J; Heydarian H; Mason K; Anixt JS
J Dev Behav Pediatr; 2023 May; 44(4):e247-e254. PubMed ID: 37081695
[TBL] [Abstract][Full Text] [Related]
7. Attention deficit disorder, stimulant use, and childhood body mass index trajectory.
Schwartz BS; Bailey-Davis L; Bandeen-Roche K; Pollak J; Hirsch AG; Nau C; Liu AY; Glass TA
Pediatrics; 2014 Apr; 133(4):668-76. PubMed ID: 24639278
[TBL] [Abstract][Full Text] [Related]
8. Sex-Specific Long-Term Height and Body Mass Index Trajectories of Children Diagnosed with Attention-Deficit/Hyperactivity Disorder and Treated with Stimulants.
Yackobovitch-Gavan M; Mimouni-Bloch A; Gabbay U; Carmi D; Goldstein B; Keinan-Boker L; Bloch S; Meyerovitch J
J Pediatr; 2021 Nov; 238():296-304.e4. PubMed ID: 34293373
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic profile and behavioral characteristics during induction of anesthesia in pediatric patients with attention deficit hyperactivity disorder.
Cartabuke RS; Tobias JD; Rice J; Tumin D
Paediatr Anaesth; 2017 Apr; 27(4):417-424. PubMed ID: 28181385
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Changes in Height, Weight, and Body Mass Index After Initiation of Central Nervous System Stimulants in Children with Attention Deficit Hyperactivity Disorder.
Waxmonsky JG; Pelham WE; Baweja R; Hale D; Pelham WE
J Pediatr; 2022 Feb; 241():115-125.e2. PubMed ID: 34571023
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
[TBL] [Abstract][Full Text] [Related]
12. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.
Schertz M; Adesman AR; Alfieri NE; Bienkowski RS
Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958
[TBL] [Abstract][Full Text] [Related]
13. Predictors of concomitant use of antipsychotics and stimulants and its impact on stimulant persistence in pediatric attention deficit hyperactivity disorder.
Bali V; Kamble PS; Aparasu RR
J Manag Care Spec Pharm; 2015 Jun; 21(6):486-98. PubMed ID: 26011550
[TBL] [Abstract][Full Text] [Related]
14. 24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy.
Stowe CD; Gardner SF; Gist CC; Schulz EG; Wells TG
Ann Pharmacother; 2002; 36(7-8):1142-9. PubMed ID: 12086544
[TBL] [Abstract][Full Text] [Related]
15. Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
Perry BA; Archer KR; Song Y; Ma Y; Green JK; Elefteriou F; Dahir KM
Osteoporos Int; 2016 Jul; 27(7):2223-2227. PubMed ID: 26928186
[TBL] [Abstract][Full Text] [Related]
16. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Palli SR; Kamble PS; Chen H; Aparasu RR
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):139-48. PubMed ID: 22364400
[TBL] [Abstract][Full Text] [Related]
17. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.
Martinez-Raga J; Knecht C; Szerman N; Martinez MI
CNS Drugs; 2013 Jan; 27(1):15-30. PubMed ID: 23160939
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
Cerrillo-Urbina AJ; García-Hermoso A; Pardo-Guijarro MJ; Sánchez-López M; Santos-Gómez JL; Martínez-Vizcaíno V
J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):494-507. PubMed ID: 29897263
[TBL] [Abstract][Full Text] [Related]
19. The longitudinal influence of ADHD status and stimulant medication on body mass index and blood pressure among youth with obesity.
Kollin SR; Lim CS; Lee AA
Pediatr Obes; 2023 Sep; 18(9):e13058. PubMed ID: 37263740
[TBL] [Abstract][Full Text] [Related]
20. Weight and Height in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Longitudinal Database Study Assessing the Impact of Guanfacine, Stimulants, and No Pharmacotherapy.
Schneider G; Banaschewski T; Feldman BL; Gustafsson PA; Murphy B; Reynolds M; Coghill DR; Spalding WM
J Child Adolesc Psychopharmacol; 2019 May; 29(4):285-304. PubMed ID: 30942617
[No Abstract] [Full Text] [Related]
[Next] [New Search]
